Participant feedback on a health care transition conference for youth with medical complexity.

An itch, or pruritus, is an impression that induces the necessity to scratch. Itch has been classified, depending on its duration, as acute (lasting <6 weeks) or chronic (>6 weeks). In several studies in Europe, the incidence of chronic pruritus ranges from 8% to 25%. In the United States, itch annually accounts for more than 7 million ambulatory consultations. Patients with chronic pruritus have diminished quality of life due to sleep problems, temperament disorders, and a negative psychosocial impact., Chronic itch is strongly associated with aging, especially in people older than 85 years. Itch in older patients may be associated with multiple factors. An important factor is the progressive loss of skin barrier function associated with aging. In addition, itch in the elderly may be produced by a general immuno-senescence described as a modification to a T helper cell type 2-mediated cytokine reply. In relation to the cause of itch, sex variances exist. While itch in men is associated with comorbid systemic diseases, in women it is more frequently associated with psychosomatic characteristics, neuropathic signals, and secondary scratch injuries. In addition, 18−20% of pregnant women suffer from pruritic disorders during pregnancy. Itch is not only associated with dermatological diseases; it is also a common symptom arising in the background of different systemic diseases, and neuropathic and psychogenic diseases. Furthermore, there is a genetic predisposition to itch. The International Forum for Study of Itch differentiates four clinical groups without considering their underlying pathophysiologic mechanisms. Group 1 (dermatologic itch), associated with skin diseases such as inflammatory, allergic, or infectious diseases and insect bites; Group 2 (systemic itch), associated with extracutaneous diseases such as from blood, kidney, liver, or other organs or drugs; Group 3 (neuropathic itch), secondary to neurologic diseases; and Group 4 (psychogenic itch), which is ascribed to psychiatric disorders. Also is common the pruritus of miscellaneous origin. The present review is focused on dermatitis-related itch (ie, Group 1), but does not exclude that many of the mechanisms described herein may also be present in the other types of itch. The molecular and cellular ways causing the itch feeling in the skin have been assessed, with special emphasis on the role of ion channels. Emerging evidence highlights the direct role of in triggering itch in atopic dermatitis (AD). Beyond its well-known ability to exacerbate inflammation through superantigens and barrier disruption, can directly activate pruriceptive sensory neurons, driving itch and scratch-induced skin injury. Recent findings demonstrate that the serine protease V8 breaks proteinase-activated receptor 1 (PAR-1) on sensory neurons, leading to heightened pruritus. Notably, inhibition of PAR-1 significantly decreases itch and skin injury caused by contact. Additionally, skin pH performs a critical role in controlling colonization and epidermal barrier function. The higher pH observed in AD promotes bacterial over-growth and alters epidermal protease activity, which in turn affects the processing of pruritogenic mediators. The itching process is started by signals from the environment under a certain genetic background that affect specific areas of the skin, in a process involving the immune system. All these circumstances produce a series of signals that activate, through ion channels, the afferent nerve fibers in the spinal circuit and brain, thus relaying the feeling of itch and inducing scratching.